The study lasts up to 13 weeks.
Mirai Depression Study
At-home depression study using your phone
Join the Mirai Depression Study with your smartphone to test the effectiveness of an investigational mobile app to help further manage depression.
Enrollment closed
Who may be eligible
- Between the ages of 22-64
- U.S. Resident
- Able to speak and read English
- Diagnosed with depression and have been on medication for at least six weeks
- Own and are the primary user of an Android or iPhone smartphone
What's involved
Participating can help researchers better understand whether the digital therapeutics within the Mirai Study App help_outline The Mirai Study App will provide participants with one of the two digital therapeutics being investigated in the Mirai Depression Study. are possible treatments for depression. If qualified, you will continue to take your prescribed medication and will be assigned to one of the two digital therapeutics help_outline App-based therapy people can access from a smartphone.within the Mirai Study App. During the study, you will:
Complete exercises
In the first 2 weeks, you’ll complete 3 practice brain exercises in the Mirai Study App.
Check-in with a Study Doctor
You’ll have video chats and phone check-ins with the Study Doctor regarding the use of the Mirai Study App, your medication and health.
Talk to a medical professional
You’ll conduct phone interviews with a mental health professional.
Use the Mirai Study App help_outline The Mirai Study App will provide participants with one of the two digital therapeutics being investigated in the Mirai Depression Study.
You will use the mobile app for up to 10 weeks.
Take surveys
You’ll answer questions about your depression symptoms and health.
What you'll receive:
Reimbursement for completion of the study
Your currently prescribed antidepressant medication and study-related tests at no costs to you while you are in the study
Exclusive access to the Project Baseline community and resources
Working together to advance research for depression.
Project Baseline is an initiative to make it easy and engaging for people like you to contribute to the map of human health and participate in clinical research. Together with researchers, clinicians, engineers, designers, advocates, and volunteers, we're collaborating to build the next generation of healthcare tools and services.
Fast facts about depression
Depression (also called major depressive disorder) is a mood disorder that causes a persistent feeling of sadness and loss of interest.1
According to the World Health Organization:
- Depression is the leading cause of disability worldwide.
- Globally, more than 322 million people of all ages suffer from depression.
1. Mayo Clinic
Project RockSTARR
If you are interested in joining this study, Otsuka would like to make a donation to a local mental health advocacy group on your behalf. Learn more about Project RockSTARR.
Mirai Depression Study
Study FAQs
In this study, the researchers want to learn more about an app, called the “Mirai Study App help_outlineThe Mirai Study App will provide participants with one of the two digital therapeutics being investigated in the Mirai Depression Study.”, participants who are already taking an antidepressant medication for their symptoms. Participants will download the Mirai Study App onto a smartphone. The app has two digital therapeutics. A digital therapeutic is a new type of therapy that people can access through software downloaded onto a phone. In this study, the Mirai Study App, containing two investigational digital therapeutics, will undergo evaluation to provide potential therapy for depression symptoms.
Otsuka is the sponsor of this study.
Project Baseline is a broad effort to better understand health and prevent disease. This study is a part of the broader initiative to better understand new possible treatments for depression.
You need to own and use an Android smartphone (OS 9.0 or greater) or an iPhone (iOS 13.0 or greater).
You will receive the Mirai Study App help_outlineThe Mirai Study App will provide participants with one of the two digital therapeutics being investigated in the Mirai Depression Study., the Project Baseline App, your antidepressant medication, and all study related tests at no costs to you while you are in the study. In addition, you may be reimbursed up to $350 to cover the costs associated with being part of this study, including cellular data charges, through a payment service.
An at-home (or remote) clinical study is one in which you can fully participate at your home. You will be assigned a study doctor who will conduct study video and phone visits with you.
Your identity and medical information will be kept confidential. We take your privacy and confidentiality seriously. A Google account is required to join this study and while Google provides the computing, analytics, and data handling power, Google will not sell your information. All your information will be stored in a secure, encrypted database with restricted access. We will not share any information with your insurance or medical providers without your consent. Please see our Privacy Policy for full details.
No. We will not share any information with your insurance or doctor without your consent.
During your participation in the study, the Mirai Study App help_outline The Mirai Study App will provide participants with one of the two digital therapeutics being investigated in the Mirai Depression Study. will be given to you at no cost.
